Error: Could not add to watchlist. X
+ Watchlist

Nivalis Therapeutics Inc

NVLS:US
NASDAQ GM
2.63
USD
0.01
0.38%
As of 8:10 PM EST 2/17/2017
Open
2.60
Day Range
2.53 - 2.63
Volume
227,491
Previous Close
2.62
52Wk Range
2.00 - 9.35
1 Yr Return
-44.63%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
2.60
Day Range
2.53 - 2.63
Volume
227,491
Previous Close
2.62
52Wk Range
2.00 - 9.35
1 Yr Return
-44.63%
YTD Return
17.41%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.04
Market Cap (m USD)
41.176
Shares Outstanding (m)
15.656
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
+0.41%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Nivalis Therapeutics, Inc. operates as a clinical stage pharmaceutical company. The Company focuses on developing a portfolio of small molecule therapeutics for the treatment of major diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, and certain cardiovascular disorders.
Address
3122 Sterling Circle
Suite 200
Boulder, CO 80301
United States
Phone
1-720-945-7700
Show More